However, our data indicated that higher CASP8 expression is found in glioma than control, the expression is highest in WHO IV, WHO III takes second place, and WHO II is the lowest, and the elevated CASP8 is associated with poor overall survival. The gene discussed is CASP8; the disease is central nervous system cancer.